ABSTRACT
Aging is thought to impair prefrontal cortical (PFC) structure-sensitive cognitive functions and flexibility, such as working memory and reversal learning. A traditional Japanese medicine, yokukansan (YKS), is frequently used to treat age-related neurodegenerative disorders such as Alzheimer's disease in Japan, but its pharmacological properties have not been elucidated. The present study was designed to examine whether YKS improves age-related cognitive deficits using aged rats. YKS was administered to 21-month-old rats for 3 months. The ability to learn initially a reward rule for a T-maze discrimination task (initial learning) was examined in young control (4-month-old), aged control (24-month-old) and YKS-treated aged (24-month-old) rats. Subsequently, working memory and reversal learning were examined in delayed alternation and reversal discrimination T-maze tasks, respectively. Locomotor activity was also measured in new environments. Although performance accuracy in the initial learning procedure did not differ among any experimental groups, accuracy in the delayed alternation task was significantly decreased in aged rats compared to young rats. Aged rats also showed significant decreases in accuracy in the reversal discrimination task. YKS treatment significantly ameliorated the age-related decreases in accuracy in the delayed alternation and reversal discrimination tasks. The ameliorative effects of YKS on impaired delayed alternation performance were reduced by intracranial infusions of a dopamine D1 receptor antagonist, SCH 23390, into the prelimbic cortical region of the PFC, and the YKS effects on impaired reversal learning were done by the infusions into the orbitofrontal cortex (OFC). Locomotor activity did not change in any experimental group. Thus, YKS ameliorated age-related impairments of working memory and reversal learning, which might be mediated by a dopaminergic mechanism in the PFC structure. These investigations provide information important for the treatment of brain dysfunctions in the elderly people.
Subject(s)
Cognition Disorders/drug therapy , Drugs, Chinese Herbal/pharmacology , Learning Disabilities/drug therapy , Memory Disorders/drug therapy , Nootropic Agents/pharmacology , Prefrontal Cortex/drug effects , Reversal Learning/physiology , Animals , Cognition Disorders/physiopathology , Cognition Disorders/psychology , Disease Models, Animal , Learning Disabilities/physiopathology , Learning Disabilities/psychology , Male , Medicine, Kampo , Memory Disorders/physiopathology , Memory Disorders/psychology , Prefrontal Cortex/metabolism , Prefrontal Cortex/physiopathology , Rats , Rats, Inbred F344 , Treatment OutcomeABSTRACT
Three THAs with cementless monolithic alumina ceramic sockets and cementless Co-alloy stems were retrieved because of aseptic loosening after 17 and 24 years. At revision heads and cups were marked for orientation. Maps were drawn of wear patterns with the use of light microscopy and surveyed by SEM. In a simulator experiment 28-mm-diameter alumina heads and liners were used. The cups were mounted inverted in a hip simulator and run with calf serum as the lubricant. The hip loads were 2 kN maximum and a 1-Hz frequency for 20 million cycles. Wear severity was classified into five grades. In retrieved implants, SEM analysis showed that the main wear zones (MWZ) had Grade 4 wear. The peripheral wear zones (PWZ) showed grain pull-out regions (Grade 5 wear). These corresponded to neck-socket impingement and head-acetabular cup separation. Gray was due to transferred CoCr particles from the stem. In the simulator study, the MWZ had only localized areas of grain pull out surrounded by polished surface regions (Grade 4 wear) at 20 million cycles; stripe wear was not seen. The alumina ceramic bearings proved excellent up to 22 years in simulator studies and clinical studies. However, microseparation kinematics would be necessary in the simulator to duplicate the more peripheral wear zones.
Subject(s)
Aluminum Oxide/chemistry , Arthroplasty, Replacement, Hip , Equipment Failure Analysis , Hip Prosthesis , Prosthesis Failure , Adult , Aged , Aged, 80 and over , Biomechanical Phenomena , Coated Materials, Biocompatible , Humans , Materials Testing , Microscopy, Electron, Scanning , Middle Aged , Prosthesis Design , Stress, Mechanical , Surface Properties , Time FactorsABSTRACT
We report a case of neurosyphilis with transient global amnesia (TGA)-like attacks on the first presentation. MRI abnormalities in bilateral limbic systems, including a few lesions in the basal ganglia and thalamus, were identified. Depression and dementia became apparent, accompanied by a high treponemal antibody titer and mild cortical atrophy. Antisyphilitic therapy brought about mild improvement, and the MRI abnormalities decreased.
Subject(s)
Amnesia/etiology , Gallium Radioisotopes , Limbic System/pathology , Magnetic Resonance Imaging , Neurosyphilis/diagnosis , Neurosyphilis/psychology , Adult , Antibodies, Bacterial/analysis , Basal Ganglia/pathology , Dementia/etiology , Depression/etiology , Humans , Male , Neurosyphilis/virology , Thalamus/pathology , Treponema pallidum/immunologyABSTRACT
BACKGROUND: Systemic administration of a cholinergic blocking agent or glucagon is used to reduce spasms, but it is inconvenient and sometimes causes side effects. This study is an evaluation of the intracolonic administration of peppermint oil during colonoscopy for the control of colonic spasm. METHODS: Each patient in the treated group (n = 409) was given approximately 200 mL of the solution (a mixture of 8 mL of peppermint oil and 0.2 mL of Tween 80 per 1 L of water with 0.04% indigo carmine) by using a hand pump attached to the accessory channel of the colonoscope. Changes in patient posture were made to distribute the solution. The patients in the control group (n = 36) were given the solution without peppermint oil. RESULTS: A satisfactory spasmolytic effect was seen in 88.5% of the treated patients and in 33.3% of those in the control group (p<0.0001). No adverse effect was observed. The mean time to onset was 21.6 +/- 15.0 seconds, and the effect continued for at least 20 minutes. In patients with irritable bowel syndrome, efficacy was significantly lower (p < 0.0001). CONCLUSIONS: The intraluminal administration of peppermint oil by using a hand pump is a simple, safe, and convenient alternative to the systemic injection of a cholinergic blocking agent or glucagon during colonoscopy.
Subject(s)
Colonic Diseases/prevention & control , Colonoscopy , Parasympatholytics/administration & dosage , Plant Oils/administration & dosage , Spasm/prevention & control , Adult , Aged , Aged, 80 and over , Colonoscopes , Equipment Design , Female , Humans , Male , Mentha piperita , Middle Aged , Preoperative CareABSTRACT
We have identified a novel type II activin receptor, called type IIA-N, the expression of which was induced during the neural differentiation of murine P19 embryonal carcinoma cells (P19 cells). P19 cells differentiate into several cell types dependent on the culture conditions. The induction of type IIA-N mRNA occurred predominantly in conjunction with neural differentiation. Sequence analysis of a cDNA clone for type IIA-N indicated that type IIA-N had a 24 bp insertion in the juxtamembrane region of the type IIA activin receptor suggesting that it is an alternative splicing product of the type IIA gene. Type IIA-N was also identified in human and Xenopus, and the amino acid sequences of three species were completely conserved. The expression of type IIA-N mRNA was specifically detected in neuroblastoma cells among several activin responsive cell lines. In vivo expression of type IIA-N mRNA was detected only in the neural tissues such as brain and spinal cord in adult mouse, by RT-PCR. Furthermore, its expression in developing Xenopus embryos was restricted to the neurula and later stages. These results suggest that the expression of type IIA-N is specific to neural cells and mediates neural differentiation-specific activin signaling.
Subject(s)
Neurons/metabolism , Receptors, Growth Factor/biosynthesis , Receptors, Growth Factor/genetics , Activin Receptors , Alternative Splicing , Amino Acid Sequence , Animals , Base Sequence , Carcinoma, Embryonal/genetics , Carcinoma, Embryonal/metabolism , Carcinoma, Embryonal/pathology , Cell Differentiation/drug effects , DNA Primers/genetics , DNA, Complementary/genetics , Gene Expression , Humans , Mice , Neurons/cytology , Neurons/drug effects , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Growth Factor/classification , Tretinoin/pharmacology , Tumor Cells, Cultured , XenopusABSTRACT
A statistical analysis of the annual day of onset of Japanese cedar pollinosis was carried out on a total of 305 patients seen at the out-patient clinic for allergic diseases in the Department of Otorhinolaryngology of Kyoto Prefectural University of Medicine between 1989 and 1991 (3 years). The day of onset varied among individuals and was distributed over a period of about one month, in patient number statistics, however, a clear single peak was seen for all 3 years. The day of onset in most patients showed tendency to peak after January 1, i.e., when the maximum temperature integral is approximately 450 degrees C, on warm days where the maximum temperature exceeds 15 degrees C, on days where there is little rain, and on days when there is a strong southerly wind. This peak onset day is about 3 weeks after first day of pollen count, or 3 or 4 days before the first dispersion peak, which corresponds to the day on which pollen dispersion begins in earnest. Furthermore, it was found that there was a drastic increase in the attack rate (from 10% to more than 50%) in pollinosis patients about 1 week before the peak day of onset. By the first dispersion peak, 70-80% of the patients had experienced an attack. The results of the present study may be useful in pollen forecasting and in treating early pollinosis in the dispersion season.
Subject(s)
Air Pollution , Rhinitis, Allergic, Seasonal/epidemiology , Atmosphere , Humans , Japan/epidemiology , Pollen , TreesABSTRACT
The energy consumption of six thoracic paraplegic persons ambulating in the reciprocating gait orthosis (RGO) with and without functional electric stimulation (FES) of their thigh muscles was determined as a function of walking speed. Plots of Kcal/kg-min and Kcal/kg-m vs walking speed in the RGO and RGO & FES were experimentally determined in this study and compared with the energy cost of walking in the long leg brace (LLB), the hip guidance orthosis (HGO), and an FES walking aid from data available in the literature. The RGO powered with electric stimulation of the thigh muscles required the lowest energy expenditure in Kcal/kg-m across the full range of walking speeds. The RGO, HGO, LLB, and FES walking orthoses ranked second, third, fourth, and fifth respectively. The lowest energy costs in Kcal/kg-min were associated with the RGO & FES, followed by the RGO, HGO, LLB, and FES for walking speeds below .28m/sec. At walking speeds higher than .28m/sec the HGO demonstrates lower energy cost followed by the RGO & FES, RGO, FES, and LLB. At the end of a 30-m walk, patients using the RGO & FES had a mean heart rate (HR) which was 12 beats/min less than the mean HR when using the RGO without FES, 31 beats/min less than the HR when using the LLB, and 42 beats/min less than the HR when using FES only. It was concluded that the FES-powered RGO combines the advantages of a passive mechanical orthosis with those of FES to provide substantial improvements in energy cost which may provide paraplegic persons with a mode of independent ambulation superior to the wheelchair.
Subject(s)
Electric Stimulation Therapy , Energy Metabolism , Gait , Muscles , Orthotic Devices , Paraplegia/therapy , Adult , Female , Humans , Locomotion , Male , ThighABSTRACT
The RGO Generation II reciprocating gait orthosis was jointly developed by Louisiana State University Medical Center and Durr-Fillauer Medical, Inc, to overcome four problems encountered with the existing model: 1) The high energy cost of locomotion; 2) the great arm strength required for patients to stand up from the seated position without assistance; 3) difficulty (especially for patients with hamstring contracture) in remaining standing owing to failure of the knee latch to lock except in full extension; and 4) problems in balancing when ambulating on an incline. The RGO Generation II employs concurrent electrostimulation of the rectus femoris and hamstrings to assist in rising and balancing and a ratchet-type latching device to improve safety and stability in standing. Alternating stimulation of the rectus femoris and contralateral hamstrings are used for locomotion. Testing in six patients with thoracic paraplegia demonstrated an average 30+% reduction in energy expenditure at a walking speed of .05 m/s and a 15+% reduction at .37 m/s; improved mobility and better balance on inclines; and unassisted rising in all patients. Walking range was increased from an average of 100 m to an average of 800 m. More research is needed to provide stair-climbing ability and to further reduce energy expenditure.
Subject(s)
Electric Stimulation Therapy/instrumentation , Gait , Leg , Muscles , Orthotic Devices/standards , Paraplegia/rehabilitation , Adult , Consumer Behavior , Contracture/rehabilitation , Energy Metabolism , Evaluation Studies as Topic , Female , Humans , Male , Paraplegia/psychology , Thoracic VertebraeABSTRACT
Myoclonus is a characteristic neurological sign of subacute sclerosing panencephalitis (SSPE). Attempts were made to induce myoclonus in a large proportion of hamsters with a cell-associated strain of SSPE virus (the Biken strain) and thereby to establish an experimental model for study of the mechanism of development of this condition. When injected intracerebrally, Biken virus induced myoclonus within two to 14 days in 84% of the three- to nine-week-old hamsters tested. Electroencephalographic traces showed a periodic and synchronous discharge consisting of high-voltage slow waves and spikes that appeared coincidentally with myoclonus. Neurons in the cortex and thalamus of the affected animals had severely degenerated cytoplasm. Inflammatory changes, such as perivascular cuffing or infiltration of mononuclear cells, were not detected. Staining with immunoperoxidase revealed measles viral antigens in the cytoplasm and dendrites of the affected neurons. SSPE virus with the same properties as the parent virus was recovered from brain cells of sick animals by cocultivation with Vero cells.